IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30

Immuron Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026

$0.96−0.03 (-2.62%)

Close on Oct 19, 2026

Immuron Ltd cash flow statement

AnnualQuarterlyTTM

AUD USD

Millions of AUD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30
Depreciation & Amortization	0.04	0.05	0.05	0.05	0.03	0.04	0.04	0.01	0.01	0.00	0.00
Stock-Based Compensation	0.09	0.30	0.00	0.23	0.09	–	0.07	1.34	0.06	0.52	-2.08
Change in Inventory	-0.53	0.48	-0.19	0.78	0.28	0.96	-0.11	0.26	-0.33	-0.28	–
Operating Cash Flow	-3.26	-6.14	-5.88	-2.60	-3.15	-4.08	-3.15	-1.80	-3.50	-6.94	-5.16
Capital Expenditures	0.00	–	0.00	-0.01	-0.01	-0.01	0.00	0.00	-0.01	-0.01	0.00
Investing Cash Flow	3.24	-2.90	0.33	-2.62	0.01	0.00	0.00	0.00	-0.01	0.00	0.00
Stock Issued	–	–	0.02	–	–	29	1.96	2.89	5.47	13	2.48
Debt Issued	–	–	–	–	–	0.21	–	–	0.50	0.50	2.95
Debt Repaid	–	–	–	–	–	-0.21	-0.37	–	-0.87	-2.19	-1.08
Financing Cash Flow	6.48	0.20	0.00	-0.04	-0.04	26	1.16	2.07	4.35	8.60	4.34
Foreign Exchange Rate Adjustments	-0.27	0.01	0.05	0.31	0.24	-0.61	0.12	0.12	-0.11	0.04	–
Net Change in Cash	6.46	-8.84	-5.55	-5.26	-3.18	22	-1.99	0.27	0.84	1.66	-0.83
Free Cash Flow	-3.26	–	-5.88	-2.60	-3.16	-4.09	-3.15	-1.80	-3.51	-6.95	-5.16
Income Taxes Paid	-1.11	-0.77	-0.40	0.25	0.31	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin: 64.5%
Operating margin: -49.9%
Net margin: -47.7%
Return on equity, FY2026: –

Financial strength

Current ratio: 7.26
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 505.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.